Adaptive Bio Ownership | Who Owns Adaptive Bio?
Adaptive Bio Ownership Summary
Adaptive Bio is owned by 97.08% institutional investors, 1.92% insiders, and 1.00% retail investors. Viking global investors lp is the largest institutional shareholder, holding 20.33% of ADPT shares. ARK Genomic Revolution is the top mutual fund, with 6.30% of its assets in Adaptive Bio shares.
ADPT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Adaptive Bio | 97.08% | 1.92% | 1.00% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Viking global investors lp | 29.99M | 20.33% | $179.81M |
Rubric capital management lp | 14.60M | 9.90% | $87.53M |
Blackrock funding, inc. /de | 12.12M | 8.22% | $72.66M |
Vanguard group | 10.71M | 7.26% | $64.24M |
Ark investment management | 9.42M | 6.39% | $56.50M |
Sumitomo mitsui trust | 6.83M | 4.63% | $40.96M |
Nikko asset management americas | 6.83M | 4.63% | $40.93M |
Millennium management | 6.29M | 4.27% | $37.72M |
Massachusetts financial services co /ma/ | 3.37M | 2.29% | $20.21M |
Soleus capital management | 2.98M | 2.02% | $17.88M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Blue water life science advisors, lp | 2.15M | 11.39% | $12.86M |
Soleus capital management | 2.98M | 1.12% | $17.88M |
Rubric capital management lp | 14.60M | 1.12% | $87.53M |
Pier capital | 1.27M | 1.09% | $7.64M |
Essex investment management | 625.84K | 0.67% | $3.75M |
Viking global investors lp | 29.99M | 0.58% | $179.81M |
Aristotle atlantic partners | 2.89M | 0.54% | $17.31M |
Ark investment management | 9.42M | 0.47% | $56.50M |
Clearline capital lp | 586.78K | 0.47% | $3.52M |
Nikko asset management americas | 6.83M | 0.44% | $40.93M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Voya investment management | 2.43M | 0.02% | 2.39M |
Soleus capital management | 2.98M | 1.12% | 1.87M |
Ameriprise financial | 736.72K | 0.00% | 654.31K |
Deutsche bank ag\ | 630.58K | 0.00% | 503.84K |
Massachusetts financial services co /ma/ | 3.37M | 0.01% | 489.56K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Millennium management | 6.29M | 0.02% | -3.11M |
Ark investment management | 9.42M | 0.47% | -2.18M |
Pictet asset management sa | 26.94K | 0.00% | -1.27M |
Nikko asset management americas | 6.83M | 0.44% | -900.75K |
Sumitomo mitsui trust | 6.83M | 0.03% | -900.75K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Exoduspoint capital management, lp | 246.87K | 0.01% | 246.87K | $1.48M |
Cinctive capital management lp | 241.32K | 0.07% | 241.32K | $1.45M |
Swiss national bank | 203.10K | 0.00% | 203.10K | $1.22M |
Trexquant investment lp | 185.87K | 0.01% | 185.87K | $1.11M |
Caxton associates lp | 123.29K | 0.02% | 123.29K | $739.11K |
Sold Out
Holder | Change |
---|---|
Northwestern mutual wealth management | -24.00 |
Srs capital advisors | -97.00 |
Bokf, na | -116.00 |
Capital performance advisors llp | -764.00 |
Group one trading | -1.62K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 209 | 11.17% | 143,202,065 | 0.07% | 97 | 1.03% | 111 | 14.43% | 45 | 2.27% |
Sep 30, 2024 | 188 | 6.21% | 143,105,692 | -3.74% | 97 | 0.93% | 97 | 5.43% | 44 | -4.35% |
Jun 30, 2024 | 177 | -7.81% | 148,665,230 | 4.35% | 101 | 1.07% | 92 | 6.98% | 46 | -30.30% |
Mar 31, 2024 | 192 | -4.48% | 142,469,885 | -0.71% | 97 | 0.99% | 86 | -10.42% | 66 | -8.33% |
Dec 31, 2023 | 201 | 4.69% | 143,483,898 | 1.57% | 99 | 1.04% | 96 | 26.32% | 72 | -1.37% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
ARK Genomic Revolution | 9.30M | 6.30% | -2.22M |
ARK Genomic Revolution ETF | 7.46M | 5.02% | 287.42K |
Nikko AM ARK Pstv Chg Innovt P JPY Acc | 4.93M | 3.32% | -152.74K |
Vanguard Total Stock Mkt Idx Inv | 4.49M | 3.02% | - |
Vanguard US Total Market Shares ETF | 4.19M | 2.82% | - |
iShares Russell 2000 ETF | 3.05M | 2.05% | -26.45K |
MFS New Discovery I | 2.20M | 1.48% | - |
Columbia Small Cap Growth Inst | 2.09M | 1.41% | 216.00K |
Nikko Gbl All Biological Genome Eq MF | 2.06M | 1.40% | -121.82K |
Vanguard Small Cap Index | 1.79M | 1.20% | 1.46K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 24, 2025 | ROBINS HARLAN S | Chief Scientific Officer | Sell | $15.28K |
Mar 13, 2025 | GRIFFIN MICHELLE RENEE | - | Sell | $260.93K |
Mar 12, 2025 | HERSHBERG ROBERT | - | Sell | $402.27K |
Mar 10, 2025 | NEUPERT PETER M | - | Sell | $70.50K |
Mar 05, 2025 | LO FRANCIS | Chief People Officer | Sell | $96.39K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 25 |
2024 Q4 | - | 1 |
2024 Q3 | - | 1 |
2024 Q2 | - | - |
2024 Q1 | - | 14 |
ADPT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools